This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Oct 26;107(43):18241-2.

doi: 10.1073/pnas.1013177107. Epub 2010 Oct 8.

Population genetics meets cancer genomics

Roland R Regoes¹

Affiliations

PMID: 20935251
PMCID: PMC2972988
DOI: 10.1073/pnas.1013177107

Comment

Population genetics meets cancer genomics

Roland R Regoes. Proc Natl Acad Sci U S A. 2010.

. 2010 Oct 26;107(43):18241-2.

doi: 10.1073/pnas.1013177107. Epub 2010 Oct 8.

Author

Roland R Regoes¹

Affiliation

¹ Institute of Integrative Biology, ETH Zurich, Zurich CH-8092, Switzerland. roland.regoes@env.ethz.ch

PMID: 20935251
PMCID: PMC2972988
DOI: 10.1073/pnas.1013177107

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: Martin Nowak, the last author of Bozic et al. (6), was the author's master's degree thesis advisor (1996–1998).

Figures

Fig. 1. — Fig. 1.
Sketch of the multitype branching process developed by Bozic et al. (6). A tumor start with one cell carrying a single driver mutation (D). This cell may either die or divide, and it can further mutate. The probabilities of these events are indicated. They depend on the number of driver mutations the cell carries and the selection coefficient s. Driver mutations arise in one of the daughter cells at division with a probability of u = 3.4 × 10⁵. The model assumes discrete generations with a length of 4 d. Passenger mutations (not shown in this sketch) are accumulated at a rate of v = 0.016 from generation to generation.

See this image and copyright information in PMC

Comment on

Accumulation of driver and passenger mutations during tumor progression.
Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Bozic I, et al. Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50. doi: 10.1073/pnas.1010978107. Epub 2010 Sep 27. Proc Natl Acad Sci U S A. 2010. PMID: 20876136 Free PMC article.

Similar articles

Accumulation of driver and passenger mutations during tumor progression.
Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, Karchin R, Kinzler KW, Vogelstein B, Nowak MA. Bozic I, et al. Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50. doi: 10.1073/pnas.1010978107. Epub 2010 Sep 27. Proc Natl Acad Sci U S A. 2010. PMID: 20876136 Free PMC article.
Measuring Clonal Evolution in Cancer with Genomics.
Williams MJ, Sottoriva A, Graham TA. Williams MJ, et al. Annu Rev Genomics Hum Genet. 2019 Aug 31;20:309-329. doi: 10.1146/annurev-genom-083117-021712. Epub 2019 May 5. Annu Rev Genomics Hum Genet. 2019. PMID: 31059289 Review.
Using the power of genetics, genomics and molecular biology to fight cancer.
Farrell PM. Farrell PM. WMJ. 2003;102(5):51-2. WMJ. 2003. PMID: 14621933 No abstract available.
Soft sweeps II--molecular population genetics of adaptation from recurrent mutation or migration.
Pennings PS, Hermisson J. Pennings PS, et al. Mol Biol Evol. 2006 May;23(5):1076-84. doi: 10.1093/molbev/msj117. Epub 2006 Mar 6. Mol Biol Evol. 2006. PMID: 16520336
Quantitative genetics in the age of genomics.
Walsh B. Walsh B. Theor Popul Biol. 2001 May;59(3):175-84. doi: 10.1006/tpbi.2001.1512. Theor Popul Biol. 2001. PMID: 11444958 Review. No abstract available.

See all similar articles

Cited by

Extreme value theory as a framework for understanding mutation frequency distribution in cancer genomes.
Tokutomi N, Nakai K, Sugano S. Tokutomi N, et al. PLoS One. 2021 Aug 23;16(8):e0243595. doi: 10.1371/journal.pone.0243595. eCollection 2021. PLoS One. 2021. PMID: 34424899 Free PMC article.
Acute myeloid leukemia in the real world: why population-based registries are needed.
Juliusson G, Lazarevic V, Hörstedt AS, Hagberg O, Höglund M; Swedish Acute Leukemia Registry Group. Juliusson G, et al. Blood. 2012 Apr 26;119(17):3890-9. doi: 10.1182/blood-2011-12-379008. Epub 2012 Mar 1. Blood. 2012. PMID: 22383796 Free PMC article.
GNAS gene mutation may be present only transiently during colorectal tumorigenesis.
Zauber P, Marotta SP, Sabbath-Solitare M. Zauber P, et al. Int J Mol Epidemiol Genet. 2016 Mar 23;7(1):24-31. eCollection 2016. Int J Mol Epidemiol Genet. 2016. PMID: 27186325 Free PMC article.
Life Entrapped in a Network of Atavistic Attractors: How to Find a Rescue.
Kasperski A. Kasperski A. Int J Mol Sci. 2022 Apr 5;23(7):4017. doi: 10.3390/ijms23074017. Int J Mol Sci. 2022. PMID: 35409376 Free PMC article. Review.
KRAS gene mutations are more common in colorectal villous adenomas and in situ carcinomas than in carcinomas.
Zauber P, Marotta S, Sabbath-Solitare M. Zauber P, et al. Int J Mol Epidemiol Genet. 2013;4(1):1-10. Epub 2013 Mar 18. Int J Mol Epidemiol Genet. 2013. PMID: 23565319 Free PMC article.

References

1. Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nat Med. 2004;10:789–799. - PubMed
1. Sjöblom T, et al. The consensus coding sequences of human breast and colorectal cancers. Science. 2006;314:268–274. - PubMed
1. Greenman C, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153–158. - PMC - PubMed
1. Parsons DW, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807–1812. - PMC - PubMed
1. Jones S, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801–1806. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources